The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fehling, H. J.
Right arrow Articles by Mathis, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fehling, H. J.
Right arrow Articles by Mathis, D.

The Journal of Immunology, Vol 144, Issue 8 2865-2874, Copyright © 1990 by American Association of Immunologists


ARTICLES

Functional consequences of overexpressed Ia antigens in AK alpha/AK beta transgenic mice

HJ Fehling, W van Ewijk, JL Pasquali, C Waltzinger, M Le Meur, P Gerlinger, C Benoist and D Mathis
Laboratoire de Genetique Moleculaire des Eucaryotes du CNRS-Unite 184 de Biologie Moleculaire et de Genie, Genetique de l-INSERM, Faculte de Medecine 11, Strasbourg, France.

We report the creation and characterization of several transgenic mouse lines that carry genes coding for the Ak alpha or Ak beta MHC class II (or Ia) molecules. In all these lines, the transgenes are expressed at the RNA and protein level with correct tissue and cell type specificity. Crosses between certain of them yield progeny displaying very high surface levels of class II protein--roughly five times the normal amount--allowing us to evaluate the consequences of quantitative variation in Ia molecule density on the organization and function of the immune system. The effects appear rather limited: we detect subtle changes in thymic lymphocyte subpopulations, as well as an enhanced Ag presentation capacity in vitro. Yet, in vivo responses are largely unaffected, and Ia overexpression to such levels does not provoke lymphoproliferation, immunodeficiency, or autoimmunity.


This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Kawamura, K. Yao, J. A. Shukaliak-Quandt, J. Huh, M. Baig, L. Quigley, N. Ito, A. Necker, H. F. McFarland, P. A. Muraro, et al.
Different Development of Myelin Basic Protein Agonist- and Antagonist-Specific Human TCR Transgenic T Cells in the Thymus and Periphery
J. Immunol., October 15, 2008; 181(8): 5462 - 5472.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gustavsson, S. Hjulstrom-Chomez, B.-M. Lidstrom, N. Ahlborg, R. Andersson, and B. Heyman
Impaired Antibody Responses in H-2Ab Mice
J. Immunol., August 15, 1998; 161(4): 1765 - 1771.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.